ReviewFrontiers in immunology2026

Beyond inhaled medications: precision medicine and biologic therapies targeting the IL-33/TSLP/type 2 axis in COPD.

Guo-Qiang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.